Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| retinal rod cell | 3 studies | 24% ± 6% |
Insufficient scRNA-seq data for expression of GUCY2F at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 64% | 4.90 | 368 / 578 | 0% | 0.00 | 2 / 1155 |
| spleen | 59% | 2.70 | 141 / 241 | 0% | 0 | 0 / 0 |
| uterus | 50% | 7.31 | 85 / 170 | 0% | 0 | 0 / 459 |
| bladder | 48% | 1.24 | 10 / 21 | 0% | 0 | 0 / 504 |
| blood vessel | 40% | 2.31 | 536 / 1335 | 0% | 0 | 0 / 0 |
| ovary | 35% | 1.27 | 63 / 180 | 0% | 0 | 0 / 430 |
| peripheral blood | 34% | 1.37 | 312 / 929 | 0% | 0 | 0 / 0 |
| brain | 32% | 1.33 | 852 / 2642 | 0% | 0.00 | 1 / 705 |
| intestine | 26% | 0.86 | 249 / 966 | 0% | 0.00 | 1 / 527 |
| kidney | 24% | 0.75 | 21 / 89 | 0% | 0.01 | 1 / 901 |
| esophagus | 21% | 0.68 | 303 / 1445 | 1% | 0.01 | 1 / 183 |
| prostate | 20% | 0.57 | 48 / 245 | 0% | 0 | 0 / 502 |
| stomach | 17% | 0.46 | 61 / 359 | 1% | 0.01 | 2 / 286 |
| adipose | 17% | 0.53 | 199 / 1204 | 0% | 0 | 0 / 0 |
| skin | 16% | 0.56 | 294 / 1809 | 0% | 0 | 0 / 472 |
| adrenal gland | 16% | 0.50 | 41 / 258 | 0% | 0 | 0 / 230 |
| breast | 13% | 0.41 | 59 / 459 | 0% | 0.00 | 1 / 1118 |
| thymus | 8% | 0.23 | 54 / 653 | 4% | 0.23 | 27 / 605 |
| muscle | 10% | 0.39 | 83 / 803 | 0% | 0 | 0 / 0 |
| heart | 10% | 0.26 | 84 / 861 | 0% | 0 | 0 / 0 |
| pancreas | 9% | 0.28 | 29 / 328 | 0% | 0 | 0 / 178 |
| liver | 4% | 0.13 | 10 / 226 | 0% | 0 | 0 / 406 |
| eye | 0% | 0 | 0 / 0 | 1% | 0.11 | 1 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0019934 | Biological process | cGMP-mediated signaling |
| GO_0007601 | Biological process | visual perception |
| GO_0006182 | Biological process | cGMP biosynthetic process |
| GO_0007168 | Biological process | receptor guanylyl cyclase signaling pathway |
| GO_0050908 | Biological process | detection of light stimulus involved in visual perception |
| GO_0022400 | Biological process | regulation of opsin-mediated signaling pathway |
| GO_0005886 | Cellular component | plasma membrane |
| GO_0005640 | Cellular component | nuclear outer membrane |
| GO_0097381 | Cellular component | photoreceptor disc membrane |
| GO_0120200 | Cellular component | rod photoreceptor outer segment |
| GO_0004016 | Molecular function | adenylate cyclase activity |
| GO_0038023 | Molecular function | signaling receptor activity |
| GO_0044877 | Molecular function | protein-containing complex binding |
| GO_0001653 | Molecular function | peptide receptor activity |
| GO_0042802 | Molecular function | identical protein binding |
| GO_0004672 | Molecular function | protein kinase activity |
| GO_0005525 | Molecular function | GTP binding |
| GO_0005524 | Molecular function | ATP binding |
| GO_0004383 | Molecular function | guanylate cyclase activity |
| Gene name | GUCY2F |
| Protein name | Retinal guanylyl cyclase 2 (RETGC-2) (EC 4.6.1.2) (Guanylate cyclase 2F, retinal) (Guanylate cyclase F) (GC-F) (Rod outer segment membrane guanylate cyclase 2) (ROS-GC2) |
| Synonyms | RETGC2 GUC2F |
| Description | FUNCTION: Responsible for the synthesis of cyclic GMP (cGMP) in rods and cones of photoreceptors . Plays an essential role in phototransduction, by mediating cGMP replenishment (By similarity). May also participate in the trafficking of membrane-asociated proteins to the photoreceptor outer segment membrane (By similarity). . |
| Accessions | P51841 ENST00000218006.3 |